Cipla

Coronavirus live updates | Curbs extended with more relaxations in Punjab till July 10

India records the second-highest number of seven-day average daily deaths in the world, next to Brazil (1,644). About 1,191 daily deaths were recorded on June 28. The two other countries with the highest fatality count after India were Colombia (678) and Russia (576). You can track coronavirus cases, deaths and testing rates at the national …

Coronavirus live updates | Curbs extended with more relaxations in Punjab till July 10 Read More »

DCGI gives emergency use nod to Moderna’s vaccine | India News

Indian pharma major Cipla will “facilitate” the import of Covid vaccines donated by US biotech major Moderna, possibly in the near future, under licence for restricted use by India’s drug regulator DCGI. In parallel, Cipla is also pursuing a separate tie-up with the US firm to undertake large-scale fill-and-finish, distribution and commercialisation of Moderna’s messenger …

DCGI gives emergency use nod to Moderna’s vaccine | India News Read More »

Coronavirus | Five firms come together for trial of COVID-19 drug Molnupiravir

Five pharma majors — Cipla, Dr. Reddy’s Laboratories, Emcure, Sun Pharma and Torrent — will collaborate for the clinical trials in India of investigational, oral, anti-viral drug Molnupiravir for the treatment of mild COVID-19 . Also read: Phase 3 trials of anti-COVID drug Molnupiravir begins Describing their collaboration as a first of its kind in …

Coronavirus | Five firms come together for trial of COVID-19 drug Molnupiravir Read More »

Five Indian drugmakers to jointly start trial of Merck & Co’s Covid-19 drug | India News

Five Indian generic drugmakers, including Cipla and Dr Reddy’s Laboratories, said on Tuesday they would jointly conduct a clinical trial of Merck & Co’s anti-viral drug to treat mild Covid-19 in non-hospitalised patients in India. Between March and April, each of these companies, which also include Sun Pharmaceutical Industries, Torrent Pharmaceuticals and privately held Emcure …

Five Indian drugmakers to jointly start trial of Merck & Co’s Covid-19 drug | India News Read More »

Cipla gets nod to import Moderna COVID-19 vaccine in India

Moderna has also informed that the U.S. government has agreed to donate to India a certain number of doses of the Moderna vaccine through COVAX Cipla Ltd. on Tuesday received approval from the country’s drugs regulator to import the COVID-19 vaccine developed by Moderna Inc. for restricted emergency use. Niti Ayog member (Health) V.K. Paul …

Cipla gets nod to import Moderna COVID-19 vaccine in India Read More »

Cipla gets DCGI nod to import Moderna’s Covid vaccine for restricted emergency use in India: Sources | India News

NEW DELHI: India’s drug regulator DCGI has granted permission to Mumbai-based pharmaceutical company Cipla to import Moderna‘s Covid-19 vaccine for restricted emergency use in the country, official sources said on Tuesday. Moderna’s vaccine will be the fourth Covid-19 jab to be available in India after Covishield, Covaxin and Sputnik. “Drugs Controller General of India (DCGI) …

Cipla gets DCGI nod to import Moderna’s Covid vaccine for restricted emergency use in India: Sources | India News Read More »

Moderna seeks regulatory approval for its COVID-19 vaccine

Mumbai-based pharmaceutical firm Cipla, on behalf of the U.S. pharma major, has requested for import and marketing authorisation of these jabs India’s drug regulator may soon grant restricted emergency use authorisation for Moderna’s COVID-19 vaccine, official sources said on June 29. Moderna has also informed that the U.S. Government has agreed to donate a certain …

Moderna seeks regulatory approval for its COVID-19 vaccine Read More »